(To read more on the industrial market, click here.)
MILFORD, MA-An unidentified publicly traded REIT acquired the36,000-sf biotech manufacturing facility at 155 Fortune Blvd. fornearly $6.9 million, or $190.28 per sf. The seller wasMassachusetts Laborers' Pension Fund. The building is 100% leasedto Avecia Biotechnology Inc.
"A committed, solid-quality, full-building tenant had renewed along-term lease," says Richard Putprush, senior director in theBoston office of Cushman & Wakefield, "and this interest rateenvironment presented a good opportunity for investors." Putprush,along with Robert E. Griffin Jr. and Christopher T. Griffin inC&W's capital markets group, represented the seller andprocured the buyer.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
